Dataset Information

Drivers of U.S. toxicological footprints trajectory 1998-2013.

ABSTRACT: By exploiting data from the Toxic Release Inventory of the United States, we have established that the toxicological footprint (TF) increased by 3.3% (88.4 Mt) between 1998 and 1999 and decreased by 39% (1088.5 Mt) between 1999 and 2013. From 1999 to 2006, the decreasing TF was driven by improvements in emissions intensity (i.e. gains in production efficiency) through toxic chemical management options: cleaner production; end of pipe treatment; transfer for further waste management; and production scale. In particular, the mining sector reduced its TF through outsourcing processes. Between 2006 and 2009, decreasing TF was due to decrease in consumption volume triggered by economic recession. Since 2009, the economic recovery increased TF, overwhelming the influence of improved emissions intensity through population growth, consumption and production structures. Accordingly, attaining a less-toxic economy and environment will be influenced by a combination of gains in production efficiency through improvement in emissions mitigation technologies and changes in consumption patterns. Overall, the current analysis highlights the structural dynamics of toxic chemical release and would inform future formulation of effective mitigation standards and management protocols towards the detoxification of the environment.

SUBMITTER: Koh SC

PROVIDER: S-EPMC5175177 | biostudies-literature | 2016 Dec

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

Drivers of U.S. toxicological footprints trajectory 1998-2013.

Koh S C L SC Ibn-Mohammed T T Acquaye A A Feng K K Reaney I M IM Hubacek K K Fujii H H Khatab K K

Scientific reports 20161221

By exploiting data from the Toxic Release Inventory of the United States, we have established that the toxicological footprint (TF) increased by 3.3% (88.4 Mt) between 1998 and 1999 and decreased by 39% (1088.5 Mt) between 1999 and 2013. From 1999 to 2006, the decreasing TF was driven by improvements in emissions intensity (i.e. gains in production efficiency) through toxic chemical management options: cleaner production; end of pipe treatment; transfer for further waste management; and producti ...[more]

PMID: 28000739

Similar Datasets

Project description:ImportanceProphylaxis and treatment guidelines for infective endocarditis have changed substantially over the past decade. In the United States, few population-based studies have explored the contemporary epidemiology and outcomes of endocarditis.ObjectiveTo quantify trends in the incidence and etiologies of infective endocarditis in the United States.Design, setting, and participantsRetrospective population epidemiology study of patients hospitalized with a first episode of endocarditis identified from mandatory state databases in California and New York State between January 1, 1998, and December 31, 2013.ExposureInfective endocarditis.Main outcomes and measuresOutcomes were crude and standardized incidence of endocarditis and trends in patient characteristics and disease etiology. Trends in acquisition mode, organism, and mortality were analyzed.ResultsAmong 75 829 patients with first episodes of endocarditis (mean [SD] age, 62.3 [18.9] years; 59.1% male), the standardized annual incidence was stable between 7.6 (95% CI, 7.4 to 7.9) and 7.8 (95% CI, 7.6 to 8.0) cases per 100 000 persons (annual percentage change [APC], -0.06%; 95% CI, -0.3% to 0.2%; P = .59). From 1998 through 2013, the proportion of patients with native-valve endocarditis decreased (from 74.5% to 68.4%; APC, -0.7%; 95% CI, -0.9% to -0.5%; P < .001). Prosthetic-valve endocarditis increased (from 12.0% to 13.8%; APC, 1.3%; 95% CI, 0.8% to 1.7%; P < .001), and cardiac device-related endocarditis increased (from 1.3% to 4.1%; APC, 8.8%; 95% CI, 7.8% to 9.9%; P < .001). The proportion of patients with health care-associated nosocomial endocarditis decreased (from 17.7% to 15.3%; APC, -1.0%; 95% CI, -1.4% to -0.7%; P < .001). The proportion of patients with health care-associated nonnosocomial endocarditis increased (from 32.1% to 35.9%; APC, 0.8%; 95% CI, 0.5% to 1.1%; P < .001). The incidence of oral streptococcal endocarditis did not increase (unadjusted: APC, -0.1%; 95% CI, -0.8% to 0.6%; P = .77; adjusted: APC, -1.3%; 95% CI, -1.8% to -0.7%; P < .001). Crude 90-day mortality was unchanged (from 23.9% to 24.2%; APC, -0.3%; 95% CI, -1.0% to 0.4%; P = .44); adjusted risk of 90-day mortality decreased (adjusted hazard ratio per year, 0.982; 95% CI, 0.978 to 0.986; P < .001).Conclusions and relevanceIn California and New York State, the overall standardized incidence of infective endocarditis was stable from 1998 through 2013, with changes in patient characteristics and etiology over this time.

Dataset Information

Drivers of U.S. toxicological footprints trajectory 1998-2013.

Publications

Drivers of U.S. toxicological footprints trajectory 1998-2013.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets